Xalkori
Xalkori 250mg 60Hard Gel Capsules
E£ 53.362,00
Quantity
1
Free delivery over 300 EGP · 24hr express in Cairo
100% authentic — licensed Egyptian pharmacy
14-day return on unopened items
Targeted therapy for ALK-positive or ROS1-positive metastatic lung cancer.
Active Ingredient: Crizotinib Non-small cell lung cancer, metastatic: Treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK)-positive or are ROS1-positive (as detected by an approved test)
BUNDLE & SAVE
Frequently bought together
PAIRS WELL WITH
Complete the routine
YOU MAY ALSO LIKE
Related products
CONTINUE BROWSING